Literature DB >> 11292787

YopB of Yersinia enterocolitica is essential for YopE translocation.

R Nordfelth1, H Wolf-Watz.   

Abstract

A previous study has shown that YopB of Yersinia spp. is essential for translocation of Yop effectors across the eucaryotic plasma membrane (M.-P. Sory and G. R. Cornelis, Mol. Microbiol. 14:583--594, 1994). However, this role was recently challenged (V. T. Lee and O. Schneewind, Mol. Microbiol. 31:1619--1629, 1999). Using protease protection and digitonin extraction, we reconfirm that YopB of Yersinia enterocolitica is essential for the translocation of YopE into HeLa cell monolayers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11292787      PMCID: PMC98323          DOI: 10.1128/IAI.69.5.3516-3518.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  LcrV is a channel size-determining component of the Yop effector translocon of Yersinia.

Authors:  A Holmström; J Olsson; P Cherepanov; E Maier; R Nordfelth; J Pettersson; R Benz; H Wolf-Watz; A Forsberg
Journal:  Mol Microbiol       Date:  2001-02       Impact factor: 3.501

2.  LcrV, a substrate for Yersinia enterocolitica type III secretion, is required for toxin targeting into the cytosol of HeLa cells.

Authors:  V T Lee; C Tam; O Schneewind
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

3.  LcrV of Yersinia pestis enters infected eukaryotic cells by a virulence plasmid-independent mechanism.

Authors:  K A Fields; S C Straley
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

4.  Status of YopM and YopN in the Yersinia Yop virulon: YopM of Y.enterocolitica is internalized inside the cytosol of PU5-1.8 macrophages by the YopB, D, N delivery apparatus.

Authors:  A Boland; M P Sory; M Iriarte; C Kerbourch; P Wattiau; G R Cornelis
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

5.  Yersinia enterocolitica TyeA, an intracellular regulator of the type III machinery, is required for specific targeting of YopE, YopH, YopM, and YopN into the cytosol of eukaryotic cells.

Authors:  L W Cheng; O Schneewind
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

6.  SycE, a chaperone-like protein of Yersinia enterocolitica involved in Ohe secretion of YopE.

Authors:  P Wattiau; G R Cornelis
Journal:  Mol Microbiol       Date:  1993-04       Impact factor: 3.501

7.  Endocytosis of Salmonella typhimurium 395 MS and MR10 by HeLa cells.

Authors:  E Kihlström; L Nilsson
Journal:  Acta Pathol Microbiol Scand B       Date:  1977-10

8.  Comparison of the invasion strategies used by Salmonella cholerae-suis, Shigella flexneri and Yersinia enterocolitica to enter cultured animal cells: endosome acidification is not required for bacterial invasion or intracellular replication.

Authors:  B B Finlay; S Falkow
Journal:  Biochimie       Date:  1988-08       Impact factor: 4.079

9.  Translocation of a hybrid YopE-adenylate cyclase from Yersinia enterocolitica into HeLa cells.

Authors:  M P Sory; G R Cornelis
Journal:  Mol Microbiol       Date:  1994-11       Impact factor: 3.501

10.  Functional conservation of the secretion and translocation machinery for virulence proteins of yersiniae, salmonellae and shigellae.

Authors:  R Rosqvist; S Håkansson; A Forsberg; H Wolf-Watz
Journal:  EMBO J       Date:  1995-09-01       Impact factor: 11.598

View more
  27 in total

1.  Protein binding between PcrG-PcrV and PcrH-PopB/PopD encoded by the pcrGVH-popBD operon of the Pseudomonas aeruginosa type III secretion system.

Authors:  Leonard R Allmond; Timur J Karaca; Vinh N Nguyen; Thong Nguyen; Jeanine P Wiener-Kronish; Teiji Sawa
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

2.  A solvent-exposed patch in chaperone-bound YopE is required for translocation by the type III secretion system.

Authors:  Loren Rodgers; Romila Mukerjea; Sara Birtalan; Devorah Friedberg; Partho Ghosh
Journal:  J Bacteriol       Date:  2010-04-09       Impact factor: 3.490

Review 3.  Process of protein transport by the type III secretion system.

Authors:  Partho Ghosh
Journal:  Microbiol Mol Biol Rev       Date:  2004-12       Impact factor: 11.056

4.  Small-molecule inhibitors specifically targeting type III secretion.

Authors:  R Nordfelth; A M Kauppi; H A Norberg; H Wolf-Watz; M Elofsson
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

5.  Expression of the Yersinia enterocolitica pYV-encoded type III secretion system is modulated by lipopolysaccharide O-antigen status.

Authors:  Camino Pérez-Gutiérrez; Catalina M Llompart; Mikael Skurnik; José A Bengoechea
Journal:  Infect Immun       Date:  2006-12-18       Impact factor: 3.441

6.  Measurement of effector protein injection by type III and type IV secretion systems by using a 13-residue phosphorylatable glycogen synthase kinase tag.

Authors:  Julie Torruellas Garcia; Franco Ferracci; Michael W Jackson; Sabrina S Joseph; Isabelle Pattis; Lisa R W Plano; Wolfgang Fischer; Gregory V Plano
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

7.  Mutations in the Yersinia pseudotuberculosis type III secretion system needle protein, YscF, that specifically abrogate effector translocation into host cells.

Authors:  Alison J Davis; Joan Mecsas
Journal:  J Bacteriol       Date:  2006-10-27       Impact factor: 3.490

8.  YscP and YscU regulate substrate specificity of the Yersinia type III secretion system.

Authors:  Petra J Edqvist; Jan Olsson; Moa Lavander; Lena Sundberg; Ake Forsberg; Hans Wolf-Watz; Scott A Lloyd
Journal:  J Bacteriol       Date:  2003-04       Impact factor: 3.490

9.  ExoS controls the cell contact-mediated switch to effector secretion in Pseudomonas aeruginosa.

Authors:  Michelle Cisz; Pei-Chung Lee; Arne Rietsch
Journal:  J Bacteriol       Date:  2007-11-26       Impact factor: 3.490

10.  Salmonella type III secretion-associated protein InvE controls translocation of effector proteins into host cells.

Authors:  Tomoko Kubori; Jorge E Galán
Journal:  J Bacteriol       Date:  2002-09       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.